Xing Zhang, Yuanyuan Song, Jie Wang, Chunyan Wu, Hanhui Xiang, Jiawei Hu, Hongyang Gong & Mingkuan Sun. (2023) Chronic exposure to titanium dioxide nanoparticles induces deficits of locomotor behavior by disrupting the development of NMJ in Drosophila. Science of The Total Environment 888, pages 164076.
Crossref
Chaoyi Deng, Jin Liu & Wensheng Zhang. (2022) Structural Modification in Anesthetic Drug Development for Prodrugs and Soft Drugs. Frontiers in Pharmacology 13.
Crossref
Yashumati Ratan Bhardwaj, Ashutosh Pareek, Vivek Jain & Dharma Kishore. (2014) Chemical delivery systems and soft drugs: Retrometabolic approaches of drug design. Saudi Pharmaceutical Journal 22:4, pages 290-302.
Crossref
Nicholas Bodor & Peter Buchwald. 2012. Retrometabolic Drug Design and Targeting. Retrometabolic Drug Design and Targeting
77
258
.
Donald J. AbrahamNicholas Bodor & Peter Buchwald. 2003. Burger's Medicinal Chemistry and Drug Discovery. Burger's Medicinal Chemistry and Drug Discovery
73
190
.
Nicholas Bodor & Peter Buchwald. (2005) Ophthalmic drug design based on the metabolic activity of the eye: Soft drugs and chemical delivery systems. The AAPS Journal 7:4, pages E820-E833.
Crossref
Donald J. AbrahamNicholas Bodor & Peter Buchwald. 2003. Burger's Medicinal Chemistry and Drug Discovery. Burger's Medicinal Chemistry and Drug Discovery
533
608
.
Nicholas Bodor & Peter Buchwald. 2001. Drug Targeting Technology. Drug Targeting Technology.
Nicholas Bodor & Peter Buchwald. (2000) Soft drug design: General principles and recent applications. Medicinal Research Reviews 20:1, pages 58-101.
Crossref
N. Bodor, P. Buchwald & M.-J. Huang. 1999. Computational Molecular Biology. Computational Molecular Biology
569
618
.
E. Damatte, M. J. Galmier, C. Lartigue-Mattei, J. F. Pognat, N. Busch & J. L. Chabard. (1996) Comparative study of the biotransformation of bepridil analogs in isolated liver cells from one rat. Relationships between structure and in vitro liver toxicity. European Journal of Drug Metabolism and Pharmacokinetics 21:4, pages 315-325.
Crossref
Henry W. Strobel, Anne V. Hodgson & Sijiu Shen. 1995. Cytochrome P450. Cytochrome P450
225
244
.
Marie-Hélène Bani, Jean-Franc??is Narbonne, Morio Fukuhara, Fusao Ushio & Larry W. Robertson. (1994) Differential modulation of hepatic cytochrome P-450 enzymes in rat and syrian hamster by 4′-trifluoromethyl-2,3,4,5-tetrachlorobiphenyl. Journal of Biochemical Toxicology 9:5, pages 241-248.
Crossref
Richard A. Willson. (1991) The Liver. Immunology and Allergy Clinics of North America 11:3, pages 555-574.
Crossref
Mukul Das, Kalpana Garg, Giriraj B. Singh & Subhash K. Khanna. (1991) Bio-elimination and organ retention profile of benzanthrone in scorbutic and non-scorbutic guinea pigs. Biochemical and Biophysical Research Communications 178:3, pages 1405-1412.
Crossref
Eric F. Johnson. (1991) A Partnership Between the Dioxin Receptor and a Basic Helix-Loop-Helix Protein. Science 252:5008, pages 924-925.
Crossref
Yasuhiro NISHIBE, Mitsuko HAMATAKA, Toshiaki HASEGAWA, Jiro IKEUCHI, Toshio YOSHIZAKI, Akira TOUCHI & Takashi MATSUBARA. (1989) Species and Sex Differences in the Inhibitory Action of the Corticosteroid Alclometasone Dipropionate on the Hepatic Drug-Metabolizing System. Japanese Journal of Pharmacology 50:4, pages 435-441.
Crossref
N. M. Boyd & P. C. Reade. (1988) Factors associated with the development of neoplasia. Journal of Oral Pathology and Medicine 17:5, pages 202-207.
Crossref
Ronald A. Jordan & Thomas F. Woolf. (1987) Basic Concepts in Drug Metabolism: Part II. The Journal of Clinical Pharmacology 27:2, pages 87-90.
Crossref
Anders Åström & Joseph W. DePierre. (1986) Rat-liver microsomal cytochrome P-450: purification, characterization, multiplicity and induction. Biochimica et Biophysica Acta (BBA) - Reviews on Bioenergetics 853:1, pages 1-27.
Crossref
Orisa J. Igwe, Shane S. Que Hee & William D. Wagner. (1986) Inhalation pharmacokinetics of 1,2-dichloroethane after different dietary pretreatments of male Sprague-Dawley rats. Archives of Toxicology 59:3, pages 127-134.
Crossref
Sheila Sherlock. (1986) THE SPECTRUM OF HEPATOTOXICITY DUE TO DRUGS. The Lancet 328:8504, pages 440-444.
Crossref
James R. Gillette. 1986. Biological Reactive Intermediates III. Biological Reactive Intermediates III
63
82
.
David E. Moody, Lorna A. Taylor & Edward A. Smuckler. (1985) Immunofluorescent determination of the lobular distribution of a constitutive form of hepatic microsomal cytochrome P-450. Hepatology 5:3, pages 440-451.
Crossref
Stan Kubow, C.M. DuboseJr.Jr., E.G. Janzen, J.R. Carlson & T.M. Bray. (1983) The spin-trapping of enzymatically and chemically catalyzed free radicals from indolic compounds. Biochemical and Biophysical Research Communications 114:1, pages 168-174.
Crossref
Lawrence Fishbein. (2016) An Overview of Some Metabolic and Modulating Factors in Toxicity and Chemical Carcinogenesis. Journal of the American College of Toxicology 2:1, pages 63-89.
Crossref
James R. Carlson & Tammy M. Bray. 1983. Advances in Nutritional Research. Advances in Nutritional Research
31
55
.
Takashi MATSUBARA, Emiko YOSHIHARA, Tsuyoshi IWATA, Yoshihiro TOCHINO & Yoshimi HACHINO. (1982) BIOTRANSFORMATION OF COUMARIN DERIVATIVES (1) 7-ALKOXYCOUMARIN O-DEALKYLASE IN LIVER MICROSOMES. Japanese Journal of Pharmacology 32:1, pages 9-21.
Crossref
I. Glenn Sipes & A. Jay Gandolfi. 1982. Biological Reactive Intermediates—II. Biological Reactive Intermediates—II
603
618
.
J. H. Weisburger & G. M. Williams. 1982. Etiology: Chemical and Physical Carcinogenesis. Etiology: Chemical and Physical Carcinogenesis
241
333
.
Neville Finch. (2006) Toxicological considerations for the medicinal chemist. Medicinal Research Reviews 1:4, pages 337-372.
Crossref
James R. Gillette. 1980. Ciba Foundation Symposium 76 - Environmental Chemicals, Enzyme Function and Human Disease. Ciba Foundation Symposium 76 - Environmental Chemicals, Enzyme Function and Human Disease
191
217
.